Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexicon Pharmaceutcl (LXRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 600,437
  • Shares Outstanding, K 106,272
  • Annual Sales, $ 63,210 K
  • Annual Income, $ -120,550 K
  • 60-Month Beta 0.78
  • Price/Sales 9.85
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate -0.16
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +72.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.10 +16.86%
on 06/03/19
6.28 -5.10%
on 05/20/19
-0.24 (-3.87%)
since 05/17/19
3-Month
4.25 +40.24%
on 03/22/19
8.26 -27.85%
on 03/20/19
-1.45 (-19.57%)
since 03/15/19
52-Week
4.25 +40.24%
on 03/22/19
13.97 -57.34%
on 06/19/18
-6.95 (-53.83%)
since 06/15/18

Most Recent Stories

More News
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (VNDA , LXRX , CCXI , MYGN , ALXN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

LXRX : 6.00 (+6.19%)
VNDA : 14.72 (+0.82%)
CCXI : 8.73 (+4.68%)
Lexicon Pharmaceuticals to Present New Clinical Data at 79th American Diabetes Association Scientific Sessions

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced new analyses of clinical data for sotagliflozin will be presented at the upcoming 79 American Diabetes Association (ADA) Scientific Sessions...

LXRX : 6.00 (+6.19%)
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference:

LXRX : 6.00 (+6.19%)
Relatively Good Performance Detected in Shares of Esperion Therape in the Biotechnology Industry (ESPR , LXRX , BCRX , TGTX , EPZM )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ESPR : 50.70 (+3.11%)
LXRX : 6.00 (+6.19%)
BCRX : 3.62 (+6.78%)
Relatively Good Performance Detected in Shares of Acorda Therapeut in the Biotechnology Industry (ACOR , LXRX , AGIO , INSM , SPPI )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

LXRX : 6.00 (+6.19%)
AGIO : 50.27 (+4.62%)
ACOR : 7.73 (+2.66%)
Relatively Good Performance Detected in Shares of Veracyte Inc in the Biotechnology Industry (VCYT , NBIX , LXRX , INCY , VRTX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

VCYT : 28.38 (+2.94%)
LXRX : 6.00 (+6.19%)
NBIX : 86.04 (+2.53%)
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates

Lexicon (LXRX) delivered earnings and revenue surprises of 0.00% and -31.09%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

LXRX : 6.00 (+6.19%)
Lexicon: 1Q Earnings Snapshot

THE WOODLANDS, Texas (AP) _ Lexicon Pharmaceuticals Inc. (LXRX) on Wednesday reported a loss of $21.8 million in its first quarter.

LXRX : 6.00 (+6.19%)
Lexicon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides a Business Update

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended March 31, 2019.

LXRX : 6.00 (+6.19%)
Repligen Corp is Among the Companies in the Biotechnology Industry with the Best Relative Performance (RGEN , LXRX , STML , DVAX , CHRS )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

LXRX : 6.00 (+6.19%)
STML : 14.61 (+3.11%)
RGEN : 77.82 (+4.85%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade LXRX with:

Business Summary

Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones....

See More

Key Turning Points

2nd Resistance Point 6.03
1st Resistance Point 5.84
Last Price 6.00
1st Support Level 5.51
2nd Support Level 5.37

See More

52-Week High 13.97
Fibonacci 61.8% 10.26
Fibonacci 50% 9.11
Fibonacci 38.2% 7.96
Last Price 6.00
52-Week Low 4.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar